Does the bubble­-positive expiratory pressure (PEP) device improve secretion clearance compared to the active cycle of breathing technique (ACBT) or no intervention (control) in people with non­-cystic fibrosis bronchiectasis?

Completed

• Conditions: on-cystic fibrosis bronchiectasis; Non-cystic fibrosis bronchiectasis; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12614001233617
• Lead Sponsor: Prince of Wales Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-11-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 39

Inclusion Criteria

Confirmed diagnosis of bronchiectasis on CT
­- Reported daily sputum production
­- Ability to perform airway clearance techniques

Exclusion Criteria

- Primary diagnosis of CF, asthma, COPD
- Any contraindications to use of PEP e.g. severe haemoptysis, pneumothorax, recent AMI, exacerbation in the previous 4 weeks
- Inability to consent or understand English
- Cognitive impairment (MMSE<24)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight of sputum as measured by calibrated scales.[During 30 minutes of intervention and 60 minutes post intervention.]

Secondary Outcome Measures

Name	Time	Method
To evaluate the acceptability and perceived benefits of the bubble­PEP device by participants immediately post intervention. This will be measured by a 5 point Likert scale.[Immediately Post intervention]